Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Ravix

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|February 25, 2026
Model-Based Strategy for 6-Mercaptopurine Treatment in Acute Lymphoblastic Leukemia Maintenance Phase: Prediction of 6-TGN and 6-MMP Concentrations to Optimize TreatmentAnne Ravix, Anaïs Maillat, Eva Choong, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model-Informed Precision DosingAnne Ravix, Annie E Cathignol, Thierry Buclin, et al.
Journal of Clinical Pharmacology|January 27, 2025
Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme DiseaseAnne Ravix, Verena Gotta, Marc Pfister, et al.
Clinical Pharmacokinetics|May 2, 2026
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM StudyAnne Ravix, Yann Thoma, Annie Cathignol, et al.
Cancers|June 27, 2024
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies StudyAnne Ravix, Carole Bandiera, Evelina Cardoso, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|February 25, 2026
Model-Based Strategy for 6-Mercaptopurine Treatment in Acute Lymphoblastic Leukemia Maintenance Phase: Prediction of 6-TGN and 6-MMP Concentrations to Optimize TreatmentAnne Ravix, Anaïs Maillat, Eva Choong, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2025
Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model-Informed Precision DosingAnne Ravix, Annie E Cathignol, Thierry Buclin, et al.
Journal of Clinical Pharmacology|January 27, 2025
Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme DiseaseAnne Ravix, Verena Gotta, Marc Pfister, et al.
Clinical Pharmacokinetics|May 2, 2026
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM StudyAnne Ravix, Yann Thoma, Annie Cathignol, et al.
Cancers|June 27, 2024
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies StudyAnne Ravix, Carole Bandiera, Evelina Cardoso, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao, et al.
Pageof 1